August 2020 – Proactive Investors: One2One Virtual Conference
Preliminary Results Presentation for the year ended 31 March 2020
To view the presentation of the preliminary results for the year ended 31 March 2020 please click here.
A recording of the webcast can be accessed via the following link:
Association for research in vision and ophthalmology (ARVO) annual meeting 2019 : Jason Commander presentation
OIS: Ophthalmology Innovation & Investment – ReNeuron using hRPCs to treat inherited retinal degenerative diseases
2017 AGM Trading Update – Shareholder Presentation
September 2017: Please click here to see the slides accompanying the AGM Trading Update presentation.
CEO Presents at Cell & Gene Investor Day, April 2017, Boston
CFO Michael Hunt Presents at Shares Magazine Investor Evening – 27th October 2016
CEO Presents at the 6th Annual Cell & Gene Partnering Forum on the Mesa 2016
KOL Event June 2016 – Retinitis Pigmentosa
To view the webcast of the KOL Event on Degenerative Eye Disease – Retinitis Pigmentosa which was held IN nEW York on the 13th June 2016 click here..
CEO Presents at Cell & Gene Therapy Investor Day March 2016